EXANE DERIVATIVES - AMEDISYS INC ownership

AMEDISYS INC's ticker is AMED and the CUSIP is 023436108. A total of 287 filers reported holding AMEDISYS INC in Q2 2022. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
EXANE DERIVATIVES ownership history of AMEDISYS INC
ValueSharesWeighting
Q1 2022$861,000
+6.4%
50.0%0.00%
Q4 2021$809,000
-97.9%
5
-98.1%
0.00%
-100.0%
Q3 2021$39,361,000
-95.9%
264
-92.7%
0.01%
-95.9%
Q2 2021$957,667,000
+261.6%
3,625
+301.4%
0.22%
+178.2%
Q4 2020$264,865,000
+207.8%
903
+148.1%
0.08%
+212.0%
Q3 2020$86,056,0003640.02%
Other shareholders
AMEDISYS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Park West Asset Management LLC 751,719$70,210,5556.45%
Crabel Capital Management, LLC 83,093$7,7616.24%
ALPINE ASSOCIATES MANAGEMENT INC. 1,033,497$96,528,6205.06%
Vazirani Asset Management LLC 35,000$3,269,0005.00%
Ergoteles LLC 33,863$3,162,8044.64%
Sand Grove Capital Management LLP 282,850$26,4183.29%
GABELLI & Co INVESTMENT ADVISERS, INC. 162,973$15,221,6782.48%
BARDIN HILL MANAGEMENT PARTNERS LP 80,923$7,5582.44%
Melqart Asset Management (UK) Ltd 350,328$32,720,6352.34%
Westchester Capital Management, LLC 850,386$79,426,0522.32%
View complete list of AMEDISYS INC shareholders